search
Back to results

Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish

Primary Purpose

Dental Caries

Status
Withdrawn
Phase
Early Phase 1
Locations
Study Type
Interventional
Intervention
Sodium Fluoride
Silver diamine fluoride
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Dental Caries focused on measuring Silver diamine Fluoride, Streptococcus mutans, Caries prevention, Fluoride

Eligibility Criteria

2 Years - 6 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • ASA I without prior history of dental restorations

Exclusion Criteria:

  • Patient with: special healthcare needs, xerostomia, complicated medical history (ASA II-VI)

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    No Intervention

    Active Comparator

    Experimental

    Arm Label

    CONTROL GROUP

    Sodium Fluoride Varnish

    Silver Diamine Fluoride

    Arm Description

    Patients waiting for treatment under general Anesthesia without any intervention

    Sodium Fluoride Varnish will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia

    Silver Diamine Fluoride will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia

    Outcomes

    Primary Outcome Measures

    Salivary levels of Streptococcus mutans
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Salivary levels of Streptococcus mutans
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Salivary levels of Streptococcus mutans
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Salivary levels of Streptococcus mutans
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)

    Secondary Outcome Measures

    Full Information

    First Posted
    March 20, 2017
    Last Updated
    October 21, 2020
    Sponsor
    Yale University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03089567
    Brief Title
    Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish
    Official Title
    Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    October 2020
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    Study was not conducted. No participants were enrolled
    Study Start Date
    September 15, 2017 (Actual)
    Primary Completion Date
    January 15, 2018 (Actual)
    Study Completion Date
    January 15, 2018 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Yale University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    Yes
    Studies a U.S. FDA-regulated Device Product
    No
    Product Manufactured in and Exported from the U.S.
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Comparison of the salivary levels of Streptococcus mutans in pediatric patients with Early Childhood Caries after the application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish
    Detailed Description
    Dental caries is the most common chronic disease in children (Benjamin, 2010). Studies suggest there is a positive correlation between bacterial titers of Streptococcus mutans and dental caries (Pannu et. al., 2013). National surveys suggest children 2 to 5 years old have 27.90% of primary teeth with caries. This number near doubles to 51.17% for children 6 to 11 years old (United States, National Health and Nutrition Examination Survey, 1999-2004). The American Academy of Pediatric Dentistry discusses this prevalence, in particular the finding of caries in young children, calling it early childhood caries (ECC), defined as "the presence of 1 or more decayed (noncavitated or cavitated lesions), missing (due to caries), or filled tooth surfaces in any primary tooth in a child 71 months of age or younger" or severe early childhood caries (S-ECC), defined as any sign of smooth surface caries in children younger than three years of age (AAPD, 2008). Oral health disparities also vary by race, ethnicity and socioeconomic status. Among children ages 3-5 years old, the prevalence of dental caries was significantly higher for non-Hispanic black individuals, 19%, compared to non-Hispanic white individuals, 11%. Furthermore, the prevalence of dental caries was nearly twice as high for Hispanic individuals, 26%, compared to non-Hispanic white individuals (Dye et. al., 2012). The use of fluoride in dentistry has played a significant role in reducing the prevalence and severity of dental caries. Water fluoridation is considered to be one of the ten greatest achievements in public health of the twentieth century (CDC, 1999). Sodium Fluoride (SF) varnishes have become a mainstay in many pediatric dental practices. Despite their intended use as desensitizing agents, fluoride varnishes are used routinely to inhibit the demineralization of enamel, promote remineralization of enamel, and arrest early enamel carious lesions (Chu et. al, 2008, CDC 2001). Fluoride also interferes with cariogenic bacteria's ability to metabolize carbohydrates, reducing their acid production, and ability to adhere to tooth surfaces, possibly reducing their ability to initiate decay (CDC, 2001). The ability of fluoride, namely SF varnishes to effect bacterial counts of S. mutans has been described in a limited extent in the literature. Chandak describes fluoride varnish's ability to reduce S. mutans counts in dental plaque, suggesting another way fluoride aids in the reduction on dental caries (Chandak et. al., 2016). However, other studies do not support SF varnishes abilities to significantly reduce plaque S. mutans counts (Sajjan, et. al., 2013). Other studies attempt to examine the effects of fluoride varnishes' ability to effect S. mutans adherence and biofilm formation. In their study Chau et. al, described a reduction in S. mutans adhesion and subsequent biofilm accumulation in the presence of a number of commercially available SF varnishes (Chau et. al, 2014). Similar to fluoride compounds, the antimicrobial effects of silver containing compounds have been used in dentistry for nearly a century. The mechanism behind these compounds' antibacterial effect is derived from the bioactive silver ion's ability to disrupt and irreversibly damage vital bacterial enzyme systems (Lansdown 2006). Despite their use internationally since the early twentieth century, silver containing compounds have fallen out of favor over time. More recently, silver diamine fluoride (SDF), currently approved by the FDA for treatment of dentinal hypersensitivity, has been shown to possess caries arresting properties. The clinical applications of SDF are seemly vast. Average operating room (OR) wait times vary between providers and can range from days to months depending on such factors as the provider's availability and resources, the patient's symptomatology, medical history, and extent of treatment. The patient population served at the Yale-New Haven Hospital Pediatric Dental Center is diverse both demographically and medically. Due to the demand and need for comprehensive dental treatment under general anesthesia, average OR wait times are 4 to 6 months. Indications for OR treatment include medically complex patients, uncooperative or pre-cooperative behavior profiles, patients with extensive and multi-quadrant decay patterns, and patients who do not meet selection criteria for sedation modalities. SDF's ability to arrest dental decay allows for patients on lengthy wait list awaiting treatment in the OR to avoid having their caries progress significantly. SDF is not a solution to caries; however it can be a useful tool in stemming the progression of decay for children awaiting surgical intervention under general anesthesia. In light of SDF's ability to arrest dental caries, there is a question about its ability to impact the etiology of caries initiation, namely its effect on salivary S. mutans counts in the oral cavity. Few studies have investigated SDF's ability to alter bacterial counts in the oral environment in children. The application of SDF to human dentin blocks resulted in the development of fewer colony forming units of a number of cariogenic bacteria, including S. mutans, compared to the control group (Mei, 2013). Similar results were described in a study examining the effect of silver fluoride on S. mutans biofilm formation (Knight et. al., 2009). The impact of such an effect would be profound and could change caries management and prevention in the pediatric population (Duangthip, Chu et. al. 2016). The increased interest and popularity of SDF has the potential to change the manner in which dental caries are treated in the pediatric population. Applications can prevent more invasive and costly need for general anesthesia, or other advanced behavior management techniques, or possibly prevent the progression of decay and avoid the loss of teeth (Chu, 2000). Furthermore, the potential ability of SDF to affect the bacterial composition of the oral environment, possibly reducing the initiation of caries has the exciting potential to be a ground breaking public health achievement. Hypothesis Application of SDF on carious teeth will show a higher decrease the salivary bacterial counts of S. mutans form baseline in 2-6 years old patients with ECC when compared to S. mutans levels after sodium fluoride varnish application and no treatment Preliminary Research Design Patient selection: Healthy 2-6 years old patients with ECC awaiting comprehensive dental treatment under general anesthesia Inclusion criteria: ASA I without prior history of dental restorations Exclusion criteria: Patient with: special healthcare needs, xerostomia, complicated medical history (ASA II-VI) Experimental Groups: 30 Patients that will receive 38% SDF application 30 Patients that will receive 5% NaF varnish application 30 Patient in Control group that will receive no treatment Salivary collection: Salivary samples will be collected with SalivaBio Children's Swab. A baseline S. mutans level will be obtained and quantified using Saliva-Check Mutans (GC America). All carious teeth will receive a rubber cup and paste dental prophylaxis followed by either a topical application of 38% SDF, or 5% NaF varnish or no topical treatment. Follow up: Further measurement of S. mutans levels will be obtained at 1, 3, 6 months after initial SDF, NaF varnish applications no treatment, without dental prophylaxis. Following salivary sample collections, re-application of SDF and NaF varnish will be applied to appropriate patient groups, and no further treatment provided to control group.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Dental Caries
    Keywords
    Silver diamine Fluoride, Streptococcus mutans, Caries prevention, Fluoride

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Early Phase 1
    Interventional Study Model
    Parallel Assignment
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    CONTROL GROUP
    Arm Type
    No Intervention
    Arm Description
    Patients waiting for treatment under general Anesthesia without any intervention
    Arm Title
    Sodium Fluoride Varnish
    Arm Type
    Active Comparator
    Arm Description
    Sodium Fluoride Varnish will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia
    Arm Title
    Silver Diamine Fluoride
    Arm Type
    Experimental
    Arm Description
    Silver Diamine Fluoride will be applied at 0,1,3 months Follow ups while waiting to receive dental treatment under general anesthesia
    Intervention Type
    Drug
    Intervention Name(s)
    Sodium Fluoride
    Other Intervention Name(s)
    Duraflor
    Intervention Description
    5% Sodium Fluoride Varnish used for dental caries prevention and desensitizer
    Intervention Type
    Drug
    Intervention Name(s)
    Silver diamine fluoride
    Other Intervention Name(s)
    Advantage Arrest
    Intervention Description
    38% Silver Diamine Fluoride used for dental caries prevention and desensitizer
    Primary Outcome Measure Information:
    Title
    Salivary levels of Streptococcus mutans
    Description
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Time Frame
    Baseline
    Title
    Salivary levels of Streptococcus mutans
    Description
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Time Frame
    1 month
    Title
    Salivary levels of Streptococcus mutans
    Description
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Time Frame
    3 months
    Title
    Salivary levels of Streptococcus mutans
    Description
    Salivary samples will be obtained with Children's Swab (SalivaBio) and S. Mutans level will be measured using Saliva-Check Mutans (GC America)
    Time Frame
    6 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    2 Years
    Maximum Age & Unit of Time
    6 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: ASA I without prior history of dental restorations Exclusion Criteria: Patient with: special healthcare needs, xerostomia, complicated medical history (ASA II-VI)
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Eunice Lee, DMD
    Organizational Affiliation
    Yale New Haven Hospital
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Christel Haberland, DDS
    Organizational Affiliation
    Yale New Haven Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Comparison of the Salivary Levels of Streptococcus Mutans in Pediatric Patients With Early Childhood Caries After the Application of Silver Diamine Fluoride or 5% Sodium Fluoride Varnish

    We'll reach out to this number within 24 hrs